Development of a highly sensitive quantitative competitive PCR assay for the detection of murine cytomegalovirus DNA.
暂无分享,去创建一个
[1] S. Jonjić,et al. Hierarchical and Redundant Lymphocyte Subset Control Precludes Cytomegalovirus Replication during Latent Infection , 1998, The Journal of experimental medicine.
[2] J. Harris,et al. Latency versus Persistence or Intermittent Recurrences : Evidence for a Latent State of Murine Cytomegalovirus in the Lungs , 1996 .
[3] Y. Burstein,et al. Treatment of murine cytomegalovirus salivary-gland infection by combined therapy with ganciclovir and thymic humoral factor gamma 2. , 1996, Antiviral research.
[4] S. Henry,et al. Expression of a murine cytomegalovirus early-late protein in "latently" infected mice. , 1995, The Journal of infectious diseases.
[5] E. Mocarski,et al. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. G. Stevens,et al. Murine cytomegalovirus is present in both chronic active and latent states in persistently infected mice. , 1994, Virology.
[7] L. Steinman,et al. Competitive PCR quantification of CD4, CD8, ICAM-1, VCAM-1, and MHC class II mRNA in the central nervous system during development and resolution of experimental allergic encephalomyelitis , 1993, Journal of Neuroimmunology.
[8] C. Pomeroy,et al. Detection of latent cytomegalovirus DNA in diverse organs of mice. , 1993, The Journal of infectious diseases.
[9] S. Henry,et al. Detection of murine cytomegalovirus immediate early 1 transcripts in the spleens of latently infected mice. , 1993, The Journal of infectious diseases.
[10] K. Yee,et al. Cytomegalovirus infection presenting as acute periodontal infection in a patient infected with the human immunodeficiency virus. , 1993, Journal of clinical periodontology.
[11] M. Uhlén,et al. Human immunodeficiency virus type 1 and cytomegalovirus in saliva , 1993, Journal of medical virology.
[12] U. Koszinowski,et al. Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus , 1992, Journal of virology.
[13] M. Glick,et al. Intraoral cytomegalovirus lesion and HIV-associated periodontitis in a patient with acquired immunodeficiency syndrome. , 1991, Oral surgery, oral medicine, and oral pathology.
[14] J. Feinberg,et al. Current status of HIV therapy: II. Opportunistic diseases. , 1991, Hospital Practice.
[15] P. Klotman,et al. Detection of mouse cytomegalovirus nucleic acid in latently infected mice by in vitro enzymatic amplification. , 1990, The Journal of infectious diseases.
[16] D. Engler,et al. Allergic rhinitis: a practical approach. , 1990, Hospital practice.
[17] Y. Burstein,et al. Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV). , 1987, Clinical and experimental immunology.
[18] N. Flournoy,et al. Risk factors for cytomegalovirus infection after human marrow transplantation. , 1986, The Journal of infectious diseases.
[19] J. G. Stevens,et al. Activation of latent murine cytomegalovirus in vivo and in vitro: a pathogenetic role for acute infection. , 1982, The Journal of infectious diseases.
[20] Shanley Jd,et al. Immunosuppression reactivates and disseminates latent murine cytomegalovirus. , 1977 .
[21] E. Mocarski,et al. Cytomegalovirus latency and latency-specific transcription in hematopoietic progenitors. , 1995, Scandinavian journal of infectious diseases. Supplementum.